Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 5Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Adrenocortical Carcinoma 2ENSAT Stage I Adrenal Cortex Carcinoma 1Adrenal Gland Neoplasms 1

Interventions

pembrolizumab 3Specimen Handling 3Magnetic Resonance Spectroscopy 3cemiplimab 2camrelizumab 2cabozantinib 2apatinib 2Mitotane 2fludarabine phosphate 1dostarlimab 1Megestrol Acetate 1Interleukin-13 1Fluorodeoxyglucose F18 1Floxuridine 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Adrenocortical Carcinoma × Mitotane × Clear all
NCT06831175 2025-06-03

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

West China Hospital

Phase 2 Recruiting
28 enrolled
Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting
80 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡